
Genesis IBRC India (GENESIS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
0
Operating Income
-1.2M
Net Income
-1.2M
EPS (Diluted)
₹-0.09
Balance Sheet Metrics
Total Assets
88.4M
Total Liabilities
3.0M
Shareholders Equity
85.3M
Debt to Equity
0.04
Cash Flow Metrics
Revenue & Profitability Trend
Genesis IBRC India Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 152.0K | 172.0K | 101.0K | 73.0K | 115.0K |
Other Operating Expenses | -35.7M | 37.4M | 696.0K | 670.0K | 627.0K |
Total Operating Expenses | -35.6M | 37.6M | 797.0K | 743.0K | 742.0K |
Operating Income | 35.0M | -38.0M | -940.0K | -1.2M | -1.2M |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 0 | 3.0K | 0 | 4.0K | 0 |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 35.0M | -38.0M | -1.4M | -1.2M | -1.2M |
Income Tax | 0 | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 35.0M | -38.0M | -1.4M | -1.2M | -1.2M |
Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Key Metrics | |||||
EBITDA | 35.0M | -38.0M | -940.0K | -1.2M | -1.2M |
EPS (Basic) | ₹2.70 | ₹-2.92 | ₹-0.11 | ₹-0.09 | ₹-0.09 |
EPS (Diluted) | ₹2.70 | ₹-2.92 | ₹-0.11 | ₹-0.09 | ₹-0.09 |
Basic Shares Outstanding | 13000000 | 13000000 | 13000000 | 13000000 | 13000000 |
Diluted Shares Outstanding | 13000000 | 13000000 | 13000000 | 13000000 | 13000000 |
Income Statement Trend
Genesis IBRC India Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 57.0K | 60.0K | 71.0K | 138.0K | 89.0K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 0 | 0 | 0 | 434.0K | 434.0K |
Inventory | - | - | - | - | - |
Other Current Assets | 51.6M | 52.0M | -1.0K | 45.9M | -1 |
Total Current Assets | 88.4M | 52.1M | 89.7M | 90.9M | 92.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 88.4M | 52.1M | 89.7M | 90.9M | 92.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 374.0K | 377.0K | 377.0K | 377.0K | 377.0K |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.9M | 1.3M | 990.0K | 938.0K | 751.0K |
Total Current Liabilities | 3.0M | 1.8M | 1.4M | 1.3M | 1.2M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | - | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | - | - | -1.0K | - | - |
Total Non-Current Liabilities | 0 | 0 | -1.0K | 0 | 0 |
Total Liabilities | 3.0M | 1.8M | 1.4M | 1.3M | 1.2M |
Equity | |||||
Common Stock | 130.0M | 130.0M | 130.0M | 130.0M | 130.0M |
Retained Earnings | -83.1M | -118.1M | -80.1M | -78.8M | -77.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 85.3M | 50.3M | 88.3M | 89.6M | 90.8M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 0 | 0 |
Working Capital | 85.3M | 50.3M | 88.3M | 89.6M | 90.8M |
Balance Sheet Composition
Genesis IBRC India Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 35.0M | -38.0M | -1.4M | -1.2M | -1.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -35.0M | 31.5M | 454.0K | -10.0K | -46.0K |
Operating Cash Flow | 0 | -6.5M | -920.0K | -1.2M | -1.2M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | 0 | 0 | 0 | 0 |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | - | 0 | 0 | 0 | 0 |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 0 | - | - | - | - |
Free Cash Flow | -3.0K | -11.0K | -920.0K | -1.2M | -1.2M |
Net Change in Cash | 0 | -6.5M | -920.0K | -1.2M | -1.2M |
Cash Flow Trend
Genesis IBRC India Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
29.47
Price to Book
10.23
Price to Sales
28.00
PEG Ratio
1.03
Profitability Ratios
Profit Margin
94.96%
Operating Margin
94.96%
Return on Equity
41.08%
Return on Assets
39.67%
Financial Health
Current Ratio
29.18
Debt to Equity
0.00
Beta
0.54
Per Share Data
EPS (TTM)
₹2.68
Book Value per Share
₹7.72
Revenue per Share
₹2.86
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
genesis | 1.0B | 29.47 | 10.23 | 41.08% | 94.96% | 0.00 |
Biocon | 470.2B | 109.74 | 1.95 | 3.66% | 2.44% | 66.26 |
OneSource Specialty | 214.4B | -1,148.53 | 3.64 | -0.31% | -0.85% | 16.03 |
Zota Health Care | 46.7B | -74.47 | 19.30 | -24.83% | -17.04% | 0.61 |
Dishman Carbogen | 45.3B | 42.71 | 0.76 | 0.06% | 3.60% | 40.97 |
Panacea Biotec | 26.3B | 222.06 | 3.03 | -1.01% | 1.88% | 2.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.